United States Mitomycin C Market by Manufacturers, States, Type and Application, Forecast to 2022


Report ID : RNR-195936 Category : Medical Devices Published Date : 8/18/2017
Publisher : GlobalInfo Research Pages : 116 Format : PDF
This report studies the Mitomycin C market, Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).


Scope of the Report:
This report focuses on the Mitomycin C in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers
    Kyowa-kirin
    Intas Pharmaceuticals
    Teva
    Bristol-Myers Squibb
    Aspen
    Speciality European Pharma
    Alkem Laboratories
    Varifarma
    APOGEPHA

Market Segment by States, covering
    California
    Texas
    New York
    Florida
    Illinois

Market Segment by Type, covers
    2 Mg
    10 Mg
    40 Mg
    Other

Market Segment by Applications, can be divided into
    Cancer Treatment
    Ophthalmic Use
    Others

There are 17 Chapters to deeply display the United States Mitomycin C market.

Chapter 1, to describe Mitomycin C Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Mitomycin C, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Mitomycin C, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue,   market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Mitomycin C market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Mitomycin C Research Findings and Conclusion, Appendix, methodology and data source.
Table of Contents
1 Market Overview
    1.1 Mitomycin C Introduction
    1.2 Market Analysis by Type
        1.2.1 2 Mg
        1.2.2 10 Mg
        1.2.3 40 Mg
        1.2.4 Other
    1.3 Market Analysis by Applications
        1.3.1 Cancer Treatment
        1.3.2 Ophthalmic Use
        1.3.3 Others
    1.4 Market Analysis by States
        1.4.1 California Status and Prospect (2012-2022)
        1.4.2 Texas Status and Prospect (2012-2022)
        1.4.3 New York Status and Prospect (2012-2022)
        1.4.4 Florida Status and Prospect (2012-2022)
        1.4.5 Illinois Status and Prospect (2012-2022)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Kyowa-kirin
        2.1.1 Profile
        2.1.2 Mitomycin C Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 Kyowa-kirin Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.1.4 Business Overview
        2.1.5 Kyowa-kirin News
    2.2 Intas Pharmaceuticals
        2.2.1 Profile
        2.2.2 Mitomycin C Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 Intas Pharmaceuticals Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.2.4 Business Overview
        2.2.5 Intas Pharmaceuticals News
    2.3 Teva
        2.3.1 Profile
        2.3.2 Mitomycin C Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 Teva Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.3.4 Business Overview
        2.3.5 Teva News
    2.4 Bristol-Myers Squibb
        2.4.1 Profile
        2.4.2 Mitomycin C Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 Bristol-Myers Squibb Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.4.4 Business Overview
        2.4.5 Bristol-Myers Squibb News
    2.5 Aspen
        2.5.1 Profile
        2.5.2 Mitomycin C Type and Applications
            2.5.2.1 Type 1
            2.5.2.2 Type 2
        2.5.3 Aspen Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.5.4 Business Overview
        2.5.5 Aspen News
    2.6 Speciality European Pharma
        2.6.1 Profile
        2.6.2 Mitomycin C Type and Applications
            2.6.2.1 Type 1
            2.6.2.2 Type 2
        2.6.3 Speciality European Pharma Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.6.4 Business Overview
        2.6.5 Speciality European Pharma News
    2.7 Alkem Laboratories
        2.7.1 Profile
        2.7.2 Mitomycin C Type and Applications
            2.7.2.1 Type 1
            2.7.2.2 Type 2
        2.7.3 Alkem Laboratories Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.7.4 Business Overview
        2.7.5 Alkem Laboratories News
    2.8 Varifarma
        2.8.1 Profile
        2.8.2 Mitomycin C Type and Applications
            2.8.2.1 Type 1
            2.8.2.2 Type 2
        2.8.3 Varifarma Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.8.4 Business Overview
        2.8.5 Varifarma News
    2.9 APOGEPHA
        2.9.1 Profile
        2.9.2 Mitomycin C Type and Applications
            2.9.2.1 Type 1
            2.9.2.2 Type 2
        2.9.3 APOGEPHA Mitomycin C Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.9.4 Business Overview
        2.9.5 APOGEPHA News
3 United States Mitomycin C Market Competition, by Manufacturer
    3.1 United States Mitomycin C Sales and Market Share by Manufacturer (2016-2017)
    3.2 United States Mitomycin C Revenue and Market Share by Manufacturer (2016-2017)
    3.3 United States Mitomycin C Price by Manufacturers (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Mitomycin C Manufacturer Market Share
        3.4.2 Top 5 Mitomycin C Manufacturer Market Share
    3.5 Market Competition Trend
4 United States Mitomycin C Market Analysis by States
    4.1 United States Mitomycin C Sales Market Share by States
    4.2 United States Mitomycin C Sales by States (2012-2017)
    4.3 United States Mitomycin C Revenue (Value) by States (2012-2017)
5 United States Market Segmentation Mitomycin C by Type
    5.1 United States Mitomycin C Sales, Revenue and Market Share by Type (2012-2017)
        5.1.1 United States Mitomycin C Sales and Market Share by Type (2012-2017)
        5.1.2 United States Mitomycin C Revenue and Market Share by Type (2012-2017)
    5.2 2 Mg Sales Growth and Price
        5.2.1 United States 2 Mg Sales Growth (2012-2017)
        5.2.2 United States 2 Mg Price (2012-2017)
    5.3 10 Mg Sales Growth and Price
        5.3.1 United States 10 Mg Sales Growth (2012-2017)
        5.3.2 United States 10 Mg Price (2012-2017)
    5.4 40 Mg Sales Growth and Price
        5.4.1 United States 40 Mg Sales Growth (2012-2017)
        5.4.2 United States 40 Mg Price (2012-2017)
    5.5 Other Sales Growth and Price
        5.5.1 United States Other Sales Growth (2012-2017)
        5.5.2 United States Other Price (2012-2017)
6 United States Market Segmentation Mitomycin C by Application
    6.1 United States Mitomycin C Sales Market Share by Application (2012-2017)
    6.2 Cancer Treatment Sales Growth (2012-2017)
    6.3 Ophthalmic Use Sales Growth (2012-2017)
    6.4 Others Sales Growth (2012-2017)
7 California Mitomycin C Sales, Revenue, by Type, Application and Manufacturers
    7.1 California Mitomycin C Revenue, Sales and Growth Rate (2012-2017)
    7.2 California Mitomycin C Sales and Market Share by Type
    7.3 California Mitomycin C Sales by Application (2012-2017)
8 New York Mitomycin C Sales, Revenue, by Type, Application and Manufacturers
    8.1 New York Mitomycin C Revenue, Sales and Growth Rate (2012-2017)
    8.2 New York Mitomycin C Sales and Market Share by Type
    8.3 New York Mitomycin C Sales by Application (2012-2017)
9 Texas Mitomycin C Sales, Revenue, by Type, Application and Manufacturers
    9.1 Texas Mitomycin C Revenue, Sales and Growth Rate (2012-2017)
    9.2 Texas Mitomycin C Sales and Market Share by Type
    9.3 Texas Mitomycin C Sales by Application (2012-2017)
10 Florida Mitomycin C Sales, Revenue, by Type, Application and Manufacturers
    10.1 Florida Mitomycin C Revenue, Sales and Growth Rate (2012-2017)
    10.2 Florida Mitomycin C Sales and Market Share by Type
    10.3 Florida Mitomycin C Sales by Application (2012-2017)
11 Illinois Mitomycin C Sales, Revenue, by Type, Application and Manufacturers
    11.1 Illinois Mitomycin C Revenue, Sales and Growth Rate (2012-2017)
    11.2 Illinois Mitomycin C Sales and Market Share by Type
    11.3 Illinois Mitomycin C Sales by Application (2012-2017)
12 Mitomycin C Market Forecast (2017-2022)
    12.1 United States Mitomycin C Sales, Revenue and Growth Rate (2017-2022)
    12.2 Mitomycin C Market Forecast by States (2017-2022)
    12.3 Mitomycin C Market Forecast by Type (2017-2022)
    12.4 Mitomycin C Market Forecast by Application (2017-2022)
13 Mitomycin C Manufacturing Cost Analysis
    13.1 Mitomycin C Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Price Trend of Key Raw Materials
        13.1.3 Key Suppliers of Raw Materials
        13.1.4 Market Concentration Rate of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
        13.2.1 Raw Materials
        13.2.2 Labor Cost
        13.2.3 Manufacturing Expenses
    13.3 Manufacturing Process Analysis of Mitomycin C
14 Industrial Chain, Sourcing Strategy and Downstream Buyers
    14.1 Mitomycin C Industrial Chain Analysis
    14.2 Upstream Raw Materials Sourcing
    14.3 Raw Materials Sources of Mitomycin C Major Manufacturers in 2016
    14.4 Downstream Buyers
15 Sales Channel, Distributors, Traders and Dealers
    15.1 Sales Channel
        15.1.1 Direct Marketing
        15.1.2 Indirect Marketing
        15.1.3 Marketing Channel Future Trend
    15.2 Distributors, Traders and Dealers
16 Research Findings and Conclusion
17 Appendix
    17.1 Methodology
    17.2 Analyst Introduction
    17.3 Data Source